LAFAYETTE — A Louisiana man is suing Bristol-Myers, alleging he experienced pain and bleeding after ingesting one of the defendant's drugs.
Maurice Jackson filed a lawsuit April 19 in U.S. District Court for the Western District of Louisiana against Bristol-Myers Squibb and Pfizer, Inc. alleging violation of the Consumer Protection Law, negligence, design defect, failure to warn and breach of express warranty.
According to the complaint, Jackson ingested Eliquis, a drug prescribed by his physician for the treatment of blood clots and stroke prevention. As a direct and proximate result, the suit says, he has experienced internal bleeding, as well as severe pain and suffering, mental anguish and incurred hospital and medical expenses.
The plaintiff alleges Bristol-Myers designed, researched, manufactured, tested, advertised, promoted, marketed, sold and distributed Eliquis, while concealing its knowledge of Eliquis’ defects, from the public and the medical community and failing to disclose that there is no means to reverse the anticoagulation effects of Eliquis.
Jackson seeks a trial by jury, compensation of at least $75,000, pre-judgment and post-judgment interest, attorney fees, legal costs and such other relief the court deems proper. He is represented by attorneys Lisa Causey-Streete and Robert L. Salim of Salim-Beasley LLC in Natchitoches, Louisiana.
U.S. District Court for the Western District of Louisiana Case number 5:16-cv-00579